Latest Julio Palmaz Stories
SAN ANTONIO, Oct.
IRVINE, Calif., Aug. 26 /PRNewswire-FirstCall/ -- Endologix, Inc.
IRVINE, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Endologix, Inc.
WALTHAM, Mass., Dec.
SAN FRANCISCO, Sept. 21 /PRNewswire/ -- Julio Palmaz, M.D., of Palmaz Scientific, will be seen at next week's Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Francisco as a discussant, presenter and lecturer on Sept. 21-23, during the first three days of the event.
Positive clinical data, competitor focus, and new drug-eluting technologies to drive lower extremity procedures in Europe, according to Millennium Research Group WALTHAM, Mass., May 28 /PRNewswire/ -- According to Millennium Research Group's (MRG's) European Markets for Peripheral Vascular (PV) Devices 2009 report, rapid growth in the number of endovascular procedures that treat lower extremity peripheral artery disease in Europe is being fueled by positive clinical trial results, increased...
Julio Palmaz, M.D. made his mark on the medical world 20 years ago with the invention of the stent which revolutionized cardiac care, and now more than a million people each year undergo coronary artery stenting to repair clogged arteries. Today, Dr.
Three internationally known pediatric surgeons from The University of Texas Health Science Center at San Antonio and its academic children's hospital, CHRISTUS Santa Rosa Children's Hospital, are this year's recipients of the prestigious Julio Palmaz Award for Innovation in Healthcare and the Biosciences.
CHICAGO (Reuters) - U.S. regulators on Wednesday said they do not plan to take further action against Boston Scientific Corp.'s heart stents despite reports of more injuries related to the devices.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.